1015 15th Street, N.W., 6th Floor
Washington, DC 20005
On April 8, 2013, Hudson Institute’s Initiative on Future Innovation convened a distinguished panel of experts from business, science, public health, law, and the academic world for an off-the-record workshop on a working draft of Reclaiming Innovation in the Life Sciences: Reform FDA, Modernize its Culture by Scott Gottlieb and Tevi Troy Dr. Gottlieb is a physician and resident fellow at the American Enterprise Institute, and formerly served as deputy commissioner of the Food and Drug Administration. Mr. Troy is a visiting fellow at Hudson Institute and former deputy secretary of the U.S. Department of Health and Human Services. Reclaiming Innovation in the Life Sciences — which will be published in final form as the fourth in a series of major research papers by Hudson’s Innovation Initiative, and thereafter available for download on this page — is a careful analysis of procedural rules and regulatory guidelines governing FDA review of proposed new medical treatments and pharmaceutical products, and a prescription for major reform of that system in the interests of improved public health and economic efficiency.
Join Hudson Institute for a discussion of how the US can build a more resilient and flexible energetics base—one that can meet sustained demand while accelerating the development and fielding of new capabilities.
Join Hudson Institute for a conference with leaders from industry, government, academia, and defense to discuss the latest developments in the US-China AI competition.
Join House Armed Services Committee Chairman Mike Rogers (AL-03) for a fireside discussion with Senior Fellow Nadia Schadlow on Congress’s role in revitalizing America’s defense industrial base.
Hudson welcomes Karel Řehka, former chief of the General Staff of the Czech Armed Forces, to discuss the changing security environment in Europe and its implications for the Czech Republic, the North Atlantic Treaty Organization, and the transatlantic alliance.
